488 related articles for article (PubMed ID: 23419234)
1. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
[TBL] [Abstract][Full Text] [Related]
2. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Ketter TA
J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
Liu HY; Potter MP; Woodworth KY; Yorks DM; Petty CR; Wozniak JR; Faraone SV; Biederman J
J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):749-62.e39. PubMed ID: 21784295
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ
J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551
[TBL] [Abstract][Full Text] [Related]
5. [Lithium and anticonvulsants in bipolar depression].
Samalin L; Nourry A; Llorca PM
Encephale; 2011 Dec; 37 Suppl 3():S203-8. PubMed ID: 22212876
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
7. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
Lin YH; Chien YL
J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
[No Abstract] [Full Text] [Related]
8. Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics.
Yerevanian BI; Koek RJ; Mintz J
J Affect Disord; 2007 Nov; 103(1-3):23-8. PubMed ID: 17604119
[TBL] [Abstract][Full Text] [Related]
9. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
10. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
[TBL] [Abstract][Full Text] [Related]
11. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018.
Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC
Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809
[TBL] [Abstract][Full Text] [Related]
12. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
Hayes JF; Pitman A; Marston L; Walters K; Geddes JR; King M; Osborn DP
JAMA Psychiatry; 2016 Jun; 73(6):630-7. PubMed ID: 27167638
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacotherapy of manic-depressive mixed States].
Krüger S; Young T; Bräunig P
Psychiatr Prax; 2006 Mar; 33 Suppl 1():S32-9. PubMed ID: 16511729
[TBL] [Abstract][Full Text] [Related]
14. Bipolar disorder and the risk of fracture: A nationwide population-based cohort study.
Su JA; Cheng BH; Huang YC; Lee CP; Yang YH; Lu ML; Hsu CY; Lee Y; McIntyre RS; Chin Lin T; Chin-Hung Chen V
J Affect Disord; 2017 Aug; 218():246-252. PubMed ID: 28477503
[TBL] [Abstract][Full Text] [Related]
15. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
Ketter TA; Nasrallah HA; Fagiolini A
Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
17. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
18. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
20. Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019.
Lin CH; Chan HY; Chen CC; Chou FH
J Affect Disord; 2022 Dec; 318():386-392. PubMed ID: 36103936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
